Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.4.0.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2016
Jun. 30, 2015
Current assets:    
Cash $ 21,893 $ 9,494
Accounts receivable - trade 454 445
Work in process 58 0
Prepaid expenses and other current assets 318 182
Total current assets 22,723 10,121
Fixed assets, net of accumulated depreciation 25,775 13
Intangible assets, net of accumulated amortization 2,139 2,360
Security deposit 28 0
Total Assets 50,665 12,494
Current liabilities:    
Accounts payable (related party of $183 and $153 as of March 31, 2016 and June 30, 2015, respectively) 1,551 1,104
Accrued expenses (related party of $443 and $0 as of March 31, 2016 and June 30, 2015, respectively) 647 159
Capital lease obligation - current portion 167 0
Deferred revenue 76 0
Total Current Liabilities 2,441 1,263
Capital lease obligation - net of current portion 25,308 0
Total Liabilities $ 27,749 $ 1,263
Commitments and Contingencies
iBio, Inc. Stockholders’ Equity:    
Preferred stock - no par value; 1,000,000 shares authorized; no shares issued and outstanding $ 0 $ 0
Common stock - $0.001 par value; 175,000,000 shares authorized; 82,609,410 and 77,205,410 shares issued and outstanding as of March 31, 2016 and June 30, 2015, respectively 83 77
Additional paid-in capital 63,127 59,006
Accumulated other comprehensive loss (31) (25)
Accumulated deficit (54,914) (47,827)
Total iBio, Inc. Stockholders’ Equity 8,265 11,231
Noncontrolling interest 14,651 0
Total Equity 22,916 11,231
Total Liabilities and Equity $ 50,665 $ 12,494